Rain Yu Zhang

Chief Financial Officer

Ms. Rain Zhang has served as Anpac Bio’s CFO since March 2019.

  • Prior to joining us, Ms. Zhang served as a general manager-operation at Buckman Laboratories (Asia) Pte. Ltd. (Singapore) (a subsidiary of Bulab Holdings, Inc., a U.S. company) from 2017 to 2018 and a finance director at Buckman Laboratories Shanghai Chemicals Co., Ltd. from 2005 to 2016.
  • She became a Chartered Global Management Accountant (CGMA) in 2016 and a Certified Public Accountant in 2002. Ms. Zhang received her bachelor’s degree in accounting from Shanghai University of Finance and Economics in 1999 and master’s degree in business administration from AnTai College of Economics & Management, Shanghai Jiao Tong University in 2015.

Our world class leaders started with a question, “What if we could detect cancer before tumors start?”

Our Leadership Team

Over 200 patent applications filed globally with 107 patent applications issued.*

Our patented Cancer Differentiation Analysis (CDA) technology reinvents cancer screening and early detection with a “Blood Biopsy” that has no side effects in patients.

*As of September 30, 2019

“game changing”

CDA technology is called “game-changing” in Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.

Read the full article
©2019 Anpac Bio-Medical Science Co., Ltd.